Study: STRONG-HF trial examined rapid up-titration of heart failure medications (GDMT) after hospitalization.
Goal: Reach optimal GDMT doses within 2 weeks after discharge.
Findings:
Over 90% of patients achieved medium-to-high GDMT doses within 2 weeks.
Patients with lower blood pressure, more congestion, and higher risk markers received less up-titration.
Higher GDMT doses:
Associated with lower rates of readmission or death for heart failure within 6 months.
Led to greater improvements in quality of life.
Were safe and well-tolerated.
Implications:
Efforts should be made to quickly reach optimal GDMT doses for most patients after hospitalization for heart failure.
Individual factors like blood pressure and congestion may influence up-titration.
This approach offers potential benefits for improving outcomes and quality of life.
Note: This study focused on three main GDMT classes (RAAS inhibitors, beta-blockers, MRAs). Newer drugs like SGLT2 inhibitors were not included but might also benefit from early initiation. Further research is needed on their effectiveness in this context.
Podden och tillhörande omslagsbild på den här sidan tillhör
Bishnu Subedi. Innehållet i podden är skapat av Bishnu Subedi och inte av,
eller tillsammans med, Poddtoppen.
